Ultrastructural study of renal involvement in two females with Anderson-Fabry disease

Ultrastructural Pathology

Volumn 29, Issue 3-4, 2005, Pages 203-207

  Tosoni, Antonella ^a   Nebuloni, M ^a   Zerbi, P ^a   Vago, L ^a   Comotti, C ^b   Sessa, A ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c Nephrology and Dialysis Unit   (Italy)

Author keywords

AFD; Females; Renal disease; Storage disorder; Ultrastructural study; X linked

Indexed keywords

ALPHA GALACTOSIDASE; GLYCOSPHINGOLIPID; RESIN;

ADULT; ANDERSON FABRY DISEASE; BRAIN; CASE REPORT; CELL ULTRASTRUCTURE; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEFECT; ENZYME DEFICIENCY; FEMALE; GLOMERULUS; HEART; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY; KIDNEY BIOPSY; KIDNEY INTERSTITIUM; LIPIDOSIS; MICROSCOPY; PRIORITY JOURNAL; RARE DISEASE; SYMPTOM; THROMBOCYTE; THROMBOCYTE ACTIVATION; X CHROMOSOME LINKED DISORDER;

FABRY DISEASE; FEMALE; HUMANS; KIDNEY; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; SIBLINGS;

EID: 22244463241     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/01913120590951202     Document Type: Conference Paper

References (17)

1. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Vale D, Kinzler KE, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease, ed. 8. New York: McGraw-Hill; 2001;3:3733-3774.
2. Desnick RJ, Wasserstein MP, Banikazemi M. Fabry disease (α-Galactosidase A deficiency): renal involvement and enzyme replacement therapy. In: Schieppati A, Daina E, Sessa A, Remuzzi G, eds. Rare Kidney Diseases. Contrib Nephrol. Basel: Karger; 2001;136:174-192.
3. Elleder M. Sequelae of storage in Fabry disease-pathology and comparison with other lysosomal storage diseases. ACTA Paediatr Suppl. 2003;443:46-53.
4. Whybra C, Kampmann C, willers I, et al. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis. 2001;24:715-724.
5. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001;38:769-807.
6. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138:338-346.
7. Pastores GM, Thadhani R. Advances in the management of Anderson-Fabry disease: enzyme replacement therapy. Expert Opin Biol Ther. 2002;2:1-9.
8. Thurberg BL, Rennke H, Colvin RB, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int. 2002;62:1933-1946.
9. Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol. 2002;13(suppl):134-138.
10. Simon M, Frey H, Gruler H, Bultmann B. Glycolipid storage material in Fabry's disease: a study by electron microscopy, freeze-fracture, and digital image analysis. J Struct Biol. 1990;103:40-47.
11. Elleder M, Ledvinova J, Vosmik F, Zeman J, Stejskal D, Lageron A. An atypical ultrastructural pattern in Fabry's disease: a study on its nature and incidence in 7 cases. Ultrastruct Pathol. 1990;14:467-474.
12. Siamopoulos KC. Fabry disease: kidney involvement and enzyme replacement therapy. Kidney Int. 2004;65:744-753.
13. Sessa A, Meroni M, Battini G, et al. Renal pathological changes in Fabry disease. J Inherit Metab Dis. 2001;24(Suppl 2):66-70.
14. Grunfeld JP, Lidove O, Barbey F. Heterozygotes with Fabry's disease. In: Schieppati A, Daina E, Sessa A, Remuzzi G, eds. Rare Kidney Diseases. Contrib Nephrol. Basel: Karger; 2001;136:174-210.
15. Fukushima M, Tsuchiyama Y, Nakato T, et al. A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am J Kidney Dis. 1995;26:952-955.
16. DeGraba T, Azhar S, Dignat-George F, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000;47: 229-233.
17. Zoja C, Remuzzi G. Role of platelets in progressive glomerular diseases. Pediatr Nephrol. 1995;9:495-502.